{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:24:49Z","timestamp":1789050289374,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12035-024-04685-5","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T10:30:27Z","timestamp":1736245827000},"page":"6308-6316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Importance of Gut Microbiota Dysbiosis and Circadian Disruption\u2013Associated Biomarkers in Emergence of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Simranjit","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"4685_CR1","doi-asserted-by":"publisher","first-page":"1309075","DOI":"10.3389\/fnins.2024.1309075","volume":"18","author":"D Medeiros","year":"2024","unstructured":"Medeiros D et al (2024) Slowing Alzheimer\u2019s disease progression through probiotic supplementation. Front Neurosci 18:1309075. https:\/\/doi.org\/10.3389\/fnins.2024.1309075","journal-title":"Front Neurosci"},{"issue":"9","key":"4685_CR2","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.3390\/ijms24098148","volume":"24","author":"H Sharma","year":"2023","unstructured":"Sharma H et al (2023) Multi-targeting neuroprotective effects of Syzygium aromaticum bud extracts and their key phytocompounds against neurodegenerative diseases. Int J Mol Sci 24(9):8148","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4685_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1590\/1516-4446-2019-0629","volume":"41","author":"T Barichello","year":"2019","unstructured":"Barichello T, Giridharan VV, Dal-Pizzol F (2019) A cerebrospinal fluid biosignature for the diagnosis of Alzheimer\u2019s disease. Braz J Psychiatry 41(6):467\u2013468. https:\/\/doi.org\/10.1590\/1516-4446-2019-0629","journal-title":"Braz J Psychiatry"},{"issue":"15","key":"4685_CR4","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms22158208","volume":"22","author":"TW Yu","year":"2021","unstructured":"Yu TW, Lane HY, Lin CH (2021) Novel therapeutic approaches for Alzheimer\u2019s disease: an updated review. Int J Mol Sci 22(15):8208","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4685_CR5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/nu14030668","volume":"14","author":"A Varesi","year":"2022","unstructured":"Varesi A et al (2022) The potential role of gut microbiota in Alzheimer\u2019s disease: from diagnosis to treatment. Nutrients 14(3):668","journal-title":"Nutrients"},{"key":"4685_CR6","doi-asserted-by":"publisher","first-page":"115277","DOI":"10.1016\/j.bbr.2024.115277","volume":"476","author":"R Heydari","year":"2024","unstructured":"Heydari R et al (2024) A domestic strain of Lactobacillus rhamnosus attenuates cognitive deficit and pro-inflammatory cytokine expression in an animal model of Alzheimer\u2019s disease. Behav Brain Res 476:115277. https:\/\/doi.org\/10.1016\/j.bbr.2024.115277","journal-title":"Behav Brain Res"},{"issue":"10","key":"4685_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1080\/07420528.2024.2406545","volume":"41","author":"YJ Yan","year":"2024","unstructured":"Yan YJ, Huang CQ (2024) Cognitive impairment induced by circadian rhythm disorders involves hippocampal brain-derived neurotrophic factor reduction and amyloid-\u03b2 deposition. Chronobiol Int 41(10):1299\u20131306. https:\/\/doi.org\/10.1080\/07420528.2024.2406545","journal-title":"Chronobiol Int"},{"issue":"1","key":"4685_CR8","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1038\/s41467-022-31502-1","volume":"13","author":"S Leviatan","year":"2022","unstructured":"Leviatan S et al (2022) An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat Commun 13(1):3863. https:\/\/doi.org\/10.1038\/s41467-022-31502-1","journal-title":"Nat Commun"},{"issue":"5778","key":"4685_CR9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355\u20131359","journal-title":"Science"},{"issue":"5","key":"4685_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2982.2012.01906.x","volume":"24","author":"P Bercik","year":"2012","unstructured":"Bercik P et al (2012) Microbes and the gut-brain axis. Neurogastroenterol Motil 24(5):405\u2013413","journal-title":"Neurogastroenterol Motil"},{"key":"4685_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","volume":"129","author":"C Mancuso","year":"2018","unstructured":"Mancuso C, Santangelo R (2018) Alzheimer\u2019s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence. Pharmacol Res 129:329\u2013336","journal-title":"Pharmacol Res"},{"issue":"7480","key":"4685_CR12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451\u2013455","journal-title":"Nature"},{"issue":"6","key":"4685_CR13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.coph.2013.09.008","volume":"13","author":"PD Cani","year":"2013","unstructured":"Cani PD, Everard A, Duparc T (2013) Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13(6):935\u2013940","journal-title":"Curr Opin Pharmacol"},{"key":"4685_CR14","doi-asserted-by":"crossref","first-page":"105314","DOI":"10.1016\/j.phrs.2020.105314","volume":"164","author":"T Doifode","year":"2021","unstructured":"Doifode T et al (2021) The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology. Pharmacol Res 164:105314","journal-title":"Pharmacol Res"},{"issue":"4","key":"4685_CR15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41380-023-02017-y","volume":"28","author":"Y Huang","year":"2023","unstructured":"Huang Y et al (2023) The gut microbiome modulates the transformation of microglial subtypes. Mol Psychiatr 28(4):1611\u20131621","journal-title":"Mol Psychiatr"},{"issue":"3","key":"4685_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/nu10030365","volume":"10","author":"MK Zin\u00f6cker","year":"2018","unstructured":"Zin\u00f6cker MK, Lindseth IA (2018) The Western diet-microbiome-host interaction and its role in metabolic disease. Nutrients 10(3):365. https:\/\/doi.org\/10.3390\/nu10030365","journal-title":"Nutrients"},{"issue":"1","key":"4685_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40168-017-0296-0","volume":"5","author":"TW Buford","year":"2017","unstructured":"Buford TW (2017) (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome 5(1):80. https:\/\/doi.org\/10.1186\/s40168-017-0296-0","journal-title":"Microbiome"},{"key":"4685_CR18","doi-asserted-by":"crossref","first-page":"118627","DOI":"10.1016\/j.lfs.2020.118627","volume":"264","author":"P Kesika","year":"2021","unstructured":"Kesika P et al (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease. Life Sci 264:118627","journal-title":"Life Sci"},{"issue":"2","key":"4685_CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-200306","volume":"78","author":"M Marizzoni","year":"2020","unstructured":"Marizzoni M et al (2020) Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease. J Alzheimers Dis 78(2):683\u2013697","journal-title":"J Alzheimers Dis"},{"key":"4685_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbi.2021.09.002","volume":"98","author":"N Kim","year":"2021","unstructured":"Kim N et al (2021) Transplantation of gut microbiota derived from Alzheimer\u2019s disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice. Brain Behav Immun 98:357\u2013365. https:\/\/doi.org\/10.1016\/j.bbi.2021.09.002","journal-title":"Brain Behav Immun"},{"issue":"1","key":"4685_CR21","doi-asserted-by":"crossref","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J et al (2023) Gut-derived \u03b2-amyloid: likely a centerpiece of the gut\u2013brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes 15(1):2167172","journal-title":"Gut Microbes"},{"issue":"1","key":"4685_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2012.01.010","volume":"229","author":"MS Kahn","year":"2012","unstructured":"Kahn MS et al (2012) Prolonged elevation in hippocampal A\u03b2 and cognitive deficits following repeated endotoxin exposure in the mouse. Behav Brain Res 229(1):176\u2013184","journal-title":"Behav Brain Res"},{"issue":"1","key":"4685_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02372-z","volume":"19","author":"X-H Qian","year":"2022","unstructured":"Qian X-H et al (2022) Injection of amyloid-\u03b2 to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer\u2019s disease. J Neuroinflammation 19(1):1\u201315","journal-title":"J Neuroinflammation"},{"issue":"12","key":"4685_CR24","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1093\/brain\/awad303","volume":"146","author":"S Grabrucker","year":"2023","unstructured":"Grabrucker S et al (2023) Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis. Brain 146(12):4916\u20134934","journal-title":"Brain"},{"key":"4685_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbi.2021.03.019","volume":"95","author":"AA Willette","year":"2021","unstructured":"Willette AA et al (2021) Inflammation, negative affect, and amyloid burden in Alzheimer\u2019s disease: insights from the kynurenine pathway. Brain Behav Immun 95:216\u2013225. https:\/\/doi.org\/10.1016\/j.bbi.2021.03.019","journal-title":"Brain Behav Immun"},{"issue":"4","key":"4685_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ et al (2005) Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol Appl Neurobiol 31(4):395\u2013404","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4685_CR27","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2147\/jir.S399480","volume":"16","author":"P Ge","year":"2023","unstructured":"Ge P et al (2023) TMAO promotes NLRP3 inflammasome activation of microglia aggravating neurological injury in ischemic stroke through FTO\/IGF2BP2. J Inflamm Res 16:3699\u20133714. https:\/\/doi.org\/10.2147\/jir.S399480","journal-title":"J Inflamm Res"},{"issue":"1","key":"4685_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.120.14759","volume":"76","author":"VE Brunt","year":"2020","unstructured":"Brunt VE et al (2020) Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension 76(1):101\u2013112. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14759","journal-title":"Hypertension"},{"issue":"2","key":"4685_CR29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/nutrit\/nuab022","volume":"80","author":"P Arrona Cardoza","year":"2022","unstructured":"Arrona Cardoza P, Spillane MB, Morales Marroquin EJNR (2022) Alzheimer\u2019s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role? Nutr Rev 80(2):271\u2013281","journal-title":"Nutr Rev"},{"issue":"8","key":"4685_CR30","doi-asserted-by":"publisher","first-page":"113005","DOI":"10.1016\/j.celrep.2023.113005","volume":"42","author":"K Miyamoto","year":"2023","unstructured":"Miyamoto K et al (2023) The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis. Cell Rep 42(8):113005. https:\/\/doi.org\/10.1016\/j.celrep.2023.113005","journal-title":"Cell Rep"},{"issue":"3","key":"4685_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00109-023-02289-5","volume":"101","author":"A Salminen","year":"2023","unstructured":"Salminen A (2023) Activation of aryl hydrocarbon receptor (AhR) in Alzheimer\u2019s disease: role of tryptophan metabolites generated by gut host-microbiota. J Mol Med 101(3):201\u2013222. https:\/\/doi.org\/10.1007\/s00109-023-02289-5","journal-title":"J Mol Med"},{"key":"4685_CR32","doi-asserted-by":"publisher","first-page":"9484217","DOI":"10.1155\/2022\/9484217","volume":"2022","author":"Y Liang","year":"2022","unstructured":"Liang Y et al (2022) Kynurenine pathway metabolites as biomarkers in Alzheimer\u2019s disease. Dis Markers 2022:9484217. https:\/\/doi.org\/10.1155\/2022\/9484217","journal-title":"Dis Markers"},{"issue":"6","key":"4685_CR33","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/cells10061548","volume":"10","author":"MN Mithaiwala","year":"2021","unstructured":"Mithaiwala MN et al (2021) Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells 10(6):1548","journal-title":"Cells"},{"issue":"5","key":"4685_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2486\/indhealth.2018-0173","volume":"57","author":"A Copertaro","year":"2019","unstructured":"Copertaro A, Bracci M (2019) Working against the biological clock: a review for the Occupational Physician. Ind Health 57(5):557\u2013569. https:\/\/doi.org\/10.2486\/indhealth.2018-0173","journal-title":"Ind Health"},{"issue":"2","key":"4685_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E et al (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55(2):204\u2013211","journal-title":"Adv Med Sci"},{"key":"4685_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0329-8","volume":"10","author":"NM Vogt","year":"2018","unstructured":"Vogt NM et al (2018) The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease. Alzheimers Res Ther 10:1\u20138","journal-title":"Alzheimers Res Ther"},{"key":"4685_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-220413","volume":"90","author":"KR Zarbock","year":"2022","unstructured":"Zarbock KR et al (2022) Trimethylamine N-oxide reduces neurite density and plaque intensity in a murine model of Alzheimer\u2019s disease. J Alzheimers Dis 90:585\u2013597. https:\/\/doi.org\/10.3233\/JAD-220413","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"4685_CR38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0748730410395732","volume":"26","author":"N Cermakian","year":"2011","unstructured":"Cermakian N et al (2011) Circadian clock gene expression in brain regions of Alzheimer\u2019s disease patients and control subjects. J Biol Rhythm 26(2):160\u2013170","journal-title":"J Biol Rhythm"},{"issue":"8","key":"4685_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","volume":"19","author":"MH Hastings","year":"2018","unstructured":"Hastings MH, Maywood ES, Brancaccio M (2018) Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci 19(8):453\u2013469. https:\/\/doi.org\/10.1038\/s41583-018-0026-z","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"4685_CR40","first-page":"83","volume":"16","author":"DBB Dhas","year":"2012","unstructured":"Dhas DBB, Bhat BV, Gane DB (2012) Role of calprotectin in infection and inflammation. Curr Pediatr Res 16(2):83\u201394","journal-title":"Curr Pediatr Res"},{"issue":"4","key":"4685_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/biom12040519","volume":"12","author":"V Garcia","year":"2022","unstructured":"Garcia V, Perera YR, Chazin WJ (2022) A structural perspective on calprotectin as a ligand of receptors mediating inflammation and potential drug target. Biomolecules 12(4):519. https:\/\/doi.org\/10.3390\/biom12040519","journal-title":"Biomolecules"},{"issue":"1","key":"4685_CR42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","volume":"25","author":"K Kowalski","year":"2019","unstructured":"Kowalski K, Mulak A (2019) Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil 25(1):48","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"4685_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-013-1208-4","volume":"127","author":"C Wang","year":"2014","unstructured":"Wang C et al (2014) The role of pro-inflammatory S100A9 in Alzheimer\u2019s disease amyloid-neuroinflammatory cascade. Acta Neuropathol 127(4):507\u2013522. https:\/\/doi.org\/10.1007\/s00401-013-1208-4","journal-title":"Acta Neuropathol"},{"key":"4685_CR44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00702-015-1381-9","volume":"122","author":"F Leblhuber","year":"2015","unstructured":"Leblhuber F et al (2015) Elevated fecal calprotectin in patients with Alzheimer\u2019s dementia indicates leaky gut. J Neural Transm 122:1319\u20131322","journal-title":"J Neural Transm"},{"issue":"1","key":"4685_CR45","doi-asserted-by":"publisher","first-page":"18924","DOI":"10.1038\/s41598-023-45929-z","volume":"13","author":"MB Heston","year":"2023","unstructured":"Heston MB et al (2023) Gut inflammation associated with age and Alzheimer\u2019s disease pathology: a human cohort study. Sci Rep 13(1):18924. https:\/\/doi.org\/10.1038\/s41598-023-45929-z","journal-title":"Sci Rep"},{"issue":"5","key":"4685_CR46","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11011-022-00964-z","volume":"37","author":"F Kar","year":"2022","unstructured":"Kar F et al (2022) Probiotics ameliorates LPS induced neuroinflammation injury on A\u03b2 1\u201342, APP, \u03b3-\u03b2 secretase and BDNF levels in maternal gut microbiota and fetal neurodevelopment processes. Metab Brain Dis 37(5):1387\u20131399. https:\/\/doi.org\/10.1007\/s11011-022-00964-z","journal-title":"Metab Brain Dis"},{"issue":"1","key":"4685_CR47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-140414","volume":"43","author":"D Yu","year":"2015","unstructured":"Yu D et al (2015) The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 43(1):291\u2013302","journal-title":"J Alzheimers Dis"},{"key":"4685_CR48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12640-019-00057-3","volume":"36","author":"ML Garcez","year":"2019","unstructured":"Garcez ML, Jacobs KR, Guillemin GJ (2019) Microbiota alterations in Alzheimer\u2019s disease: involvement of the kynurenine pathway and inflammation. Neurotoxicity Res 36:424\u2013436","journal-title":"Neurotoxicity Res"},{"key":"4685_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-170485","volume":"60","author":"LM Giil","year":"2017","unstructured":"Giil LM et al (2017) Kynurenine pathway metabolites in Alzheimer\u2019s disease. J Alzheimers Dis 60:495\u2013504. https:\/\/doi.org\/10.3233\/JAD-170485","journal-title":"J Alzheimers Dis"},{"key":"4685_CR50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","volume":"263","author":"MJ Schwarz","year":"2013","unstructured":"Schwarz MJ et al (2013) Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls. Eur Arch Psychiatr Clin Neurosci 263:345\u2013352","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"issue":"4","key":"4685_CR51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/biom10040571","volume":"10","author":"M Gonz\u00e1lez-S\u00e1nchez","year":"2020","unstructured":"Gonz\u00e1lez-S\u00e1nchez M et al (2020) Kynurenic acid levels are increased in the CSF of Alzheimer\u2019s disease patients. Biomolecules 10(4):571. https:\/\/doi.org\/10.3390\/biom10040571","journal-title":"Biomolecules"},{"key":"4685_CR52","doi-asserted-by":"publisher","first-page":"113412","DOI":"10.1016\/j.biopha.2022.113412","volume":"153","author":"Q Wang","year":"2022","unstructured":"Wang Q et al (2022) The role of microglia immunometabolism in neurodegeneration: focus on molecular determinants and metabolic intermediates of metabolic reprogramming. Biomed Pharmacother 153:113412. https:\/\/doi.org\/10.1016\/j.biopha.2022.113412","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"4685_CR53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.chom.2022.05.005","volume":"30","author":"Y Teng","year":"2022","unstructured":"Teng Y et al (2022) Gut bacterial isoamylamine promotes age-related cognitive dysfunction by promoting microglial cell death. Cell Host Microbe 30(7):944-960. e8","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4685_CR54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-022-00548-6","volume":"17","author":"E Connell","year":"2022","unstructured":"Connell E et al (2022) Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia. Mol Neurodegener 17(1):43","journal-title":"Mol Neurodegener"},{"key":"4685_CR55","doi-asserted-by":"publisher","first-page":"105459","DOI":"10.1016\/j.neuint.2022.105459","volume":"162","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Trimethylamine N-oxide aggravated cognitive impairment from APP\/PS1 mice and protective roles of voluntary exercise. Neurochem Int 162:105459. https:\/\/doi.org\/10.1016\/j.neuint.2022.105459","journal-title":"Neurochem Int"},{"issue":"19","key":"4685_CR56","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.18632\/aging.102352","volume":"11","author":"Q Gao","year":"2019","unstructured":"Gao Q et al (2019) Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer\u2019s disease. Aging (Albany NY) 11(19):8642\u20138663. https:\/\/doi.org\/10.18632\/aging.102352","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"4685_CR57","doi-asserted-by":"publisher","first-page":"e12768","DOI":"10.1111\/acel.12768","volume":"17","author":"D Li","year":"2018","unstructured":"Li D et al (2018) Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell 17(4):e12768. https:\/\/doi.org\/10.1111\/acel.12768","journal-title":"Aging Cell"},{"issue":"1","key":"4685_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41522-022-00273-4","volume":"8","author":"Y-Y Cai","year":"2022","unstructured":"Cai Y-Y et al (2022) Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis. npj Biofilms Microbiomes 8(1):11. https:\/\/doi.org\/10.1038\/s41522-022-00273-4","journal-title":"npj Biofilms Microbiomes"},{"issue":"3","key":"4685_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi JS (2017) Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet 18(3):164\u2013179. https:\/\/doi.org\/10.1038\/nrg.2016.150","journal-title":"Nat Rev Genet"},{"key":"4685_CR60","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.nbd.2021.105454","volume":"158","author":"AR Fusilier","year":"2021","unstructured":"Fusilier AR et al (2021) Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice. Neurobiol Dis 158:105454. https:\/\/doi.org\/10.1016\/j.nbd.2021.105454","journal-title":"Neurobiol Dis"},{"issue":"8","key":"4685_CR61","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/ene.15385","volume":"29","author":"H Furby","year":"2022","unstructured":"Furby H et al (2022) Natural history and burden of Huntington\u2019s disease in the UK: a population-based cohort study. Eur J Neurol 29(8):2249\u20132257. https:\/\/doi.org\/10.1111\/ene.15385","journal-title":"Eur J Neurol"},{"key":"4685_CR62","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.smrv.2023.101759","volume":"68","author":"G Maggi","year":"2023","unstructured":"Maggi G et al (2023) Sleep and wakefulness disturbances in Parkinson\u2019s disease: a meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia. Sleep Med Rev 68:101759. https:\/\/doi.org\/10.1016\/j.smrv.2023.101759","journal-title":"Sleep Med Rev"},{"issue":"11","key":"4685_CR63","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40266-021-00891-1","volume":"38","author":"JP Roland","year":"2021","unstructured":"Roland JP, Bliwise DL (2021) Impact of pharmacotherapy on insomnia in patients with Alzheimer\u2019s disease. Drugs Aging 38(11):951\u2013966. https:\/\/doi.org\/10.1007\/s40266-021-00891-1","journal-title":"Drugs Aging"},{"issue":"3","key":"4685_CR64","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/emm.2014.121","volume":"47","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Xiong DD, Holtzman DM (2015) Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med 47(3):e148\u2013e148. https:\/\/doi.org\/10.1038\/emm.2014.121","journal-title":"Exp Mol Med"},{"issue":"4","key":"4685_CR65","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1084\/jem.20172347","volume":"215","author":"GJ Kress","year":"2018","unstructured":"Kress GJ et al (2018) Regulation of amyloid-\u03b2 dynamics and pathology by the circadian clock. J Exp Med 215(4):1059\u20131068. https:\/\/doi.org\/10.1084\/jem.20172347","journal-title":"J Exp Med"},{"key":"4685_CR66","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.smrv.2021.101541","volume":"60","author":"CH Lew","year":"2021","unstructured":"Lew CH et al (2021) Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer\u2019s disease. Sleep Med Rev 60:101541. https:\/\/doi.org\/10.1016\/j.smrv.2021.101541","journal-title":"Sleep Med Rev"},{"issue":"3","key":"4685_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12289","volume":"26","author":"K Stratmann","year":"2016","unstructured":"Stratmann K et al (2016) Precortical phase of Alzheimer\u2019s disease (AD)-related tau cytoskeletal pathology. Brain Pathol 26(3):371\u2013386. https:\/\/doi.org\/10.1111\/bpa.12289","journal-title":"Brain Pathol"},{"key":"4685_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2015.01.035","volume":"290","author":"M Sethi","year":"2015","unstructured":"Sethi M et al (2015) Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer\u2019s disease. Neuroscience 290:80\u201389. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.035","journal-title":"Neuroscience"},{"issue":"12","key":"4685_CR69","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jamaneurol.2013.4258","volume":"70","author":"AP Spira","year":"2013","unstructured":"Spira AP et al (2013) Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurol 70(12):1537\u20131543. https:\/\/doi.org\/10.1001\/jamaneurol.2013.4258","journal-title":"JAMA Neurol"},{"issue":"5955","key":"4685_CR70","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang JE et al (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326(5955):1005\u20131007. https:\/\/doi.org\/10.1126\/science.1180962","journal-title":"Science"},{"issue":"6156","key":"4685_CR71","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L et al (2013) Sleep drives metabolite clearance from the adult brain. Science 342(6156):373\u2013377. https:\/\/doi.org\/10.1126\/science.1241224","journal-title":"Science"},{"issue":"6","key":"4685_CR72","doi-asserted-by":"publisher","first-page":"e0130177","DOI":"10.1371\/journal.pone.0130177","volume":"10","author":"J Colby-Milley","year":"2015","unstructured":"Colby-Milley J et al (2015) Sleep-wake cycle dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease: from early to advanced pathological stages. PLoS One 10(6):e0130177. https:\/\/doi.org\/10.1371\/journal.pone.0130177","journal-title":"PLoS One"},{"key":"4685_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","volume":"135","author":"F Schneider","year":"2014","unstructured":"Schneider F et al (2014) Behavioral and EEG changes in male 5xFAD mice. Physiol Behav 135:25\u201333. https:\/\/doi.org\/10.1016\/j.physbeh.2014.05.041","journal-title":"Physiol Behav"},{"key":"4685_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbscr.2016.08.002","volume":"2","author":"J Holth","year":"2017","unstructured":"Holth J, Patel T, Holtzman DM (2017) Sleep in Alzheimer\u2019s disease - beyond amyloid. Neurobiol Sleep Circadian Rhythm 2:4\u201314. https:\/\/doi.org\/10.1016\/j.nbscr.2016.08.002","journal-title":"Neurobiol Sleep Circadian Rhythm"},{"issue":"2","key":"4685_CR75","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer\u2019s disease in individuals under thirty. Acta Neuropathol 121(2):171\u2013181. https:\/\/doi.org\/10.1007\/s00401-010-0789-4","journal-title":"Acta Neuropathol"},{"issue":"474","key":"4685_CR76","doi-asserted-by":"publisher","first-page":"eaau6550","DOI":"10.1126\/scitranslmed.aau6550","volume":"11","author":"BP Lucey","year":"2019","unstructured":"Lucey BP et al (2019) Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease. Sci Transl Med 11(474):eaau6550. https:\/\/doi.org\/10.1126\/scitranslmed.aau6550","journal-title":"Sci Transl Med"},{"issue":"3","key":"4685_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nn.3324","volume":"16","author":"BA Mander","year":"2013","unstructured":"Mander BA et al (2013) Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat Neurosci 16(3):357\u2013364. https:\/\/doi.org\/10.1038\/nn.3324","journal-title":"Nat Neurosci"},{"issue":"1","key":"4685_CR78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41398-022-01897-y","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Sleep in Alzheimer\u2019s disease: a systematic review and meta-analysis of polysomnographic findings. Transl Psychiatry 12(1):136. https:\/\/doi.org\/10.1038\/s41398-022-01897-y","journal-title":"Transl Psychiatry"},{"issue":"3","key":"4685_CR79","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00429-021-02447-w","volume":"227","author":"P Zhao","year":"2022","unstructured":"Zhao P et al (2022) Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer\u2019s disease mice. Brain Struct Funct 227(3):1051\u20131065. https:\/\/doi.org\/10.1007\/s00429-021-02447-w","journal-title":"Brain Struct Funct"},{"issue":"1","key":"4685_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/JAD-190958","volume":"73","author":"S Shimizu","year":"2020","unstructured":"Shimizu S et al (2020) Positive association between cognitive function and cerebrospinal fluid orexin A levels in Alzheimer\u2019s disease. J Alzheimers Dis 73(1):117\u2013123. https:\/\/doi.org\/10.3233\/JAD-190958","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4685_CR81","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/bpa.13028","volume":"32","author":"L Niu","year":"2022","unstructured":"Niu L et al (2022) Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer\u2019s disease neuropathology. Brain Pathol 32(3):e13028. https:\/\/doi.org\/10.1111\/bpa.13028","journal-title":"Brain Pathol"},{"issue":"6","key":"4685_CR82","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jalz.2016.10.003","volume":"13","author":"P Cronin","year":"2017","unstructured":"Cronin P et al (2017) Circadian alterations during early stages of Alzheimer\u2019s disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement 13(6):689\u2013700. https:\/\/doi.org\/10.1016\/j.jalz.2016.10.003","journal-title":"Alzheimers Dement"},{"issue":"1","key":"4685_CR83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-023-00104-6","volume":"9","author":"MR Khezri","year":"2023","unstructured":"Khezri MR, Ghasemnejad-Berenji M (2023) Gut microbiota and circadian rhythm in Alzheimer\u2019s disease pathophysiology: a review and hypothesis on their association. npj Aging 9(1):9","journal-title":"npj Aging"},{"issue":"4","key":"4685_CR84","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3233\/JAD-200634","volume":"77","author":"B Hulme","year":"2020","unstructured":"Hulme B et al (2020) Epigenetic regulation of BMAL1 with sleep disturbances and Alzheimer\u2019s disease. J Alzheimers Dis 77(4):1783\u20131792","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"4685_CR85","doi-asserted-by":"crossref","first-page":"e13704","DOI":"10.1111\/acel.13704","volume":"21","author":"R Fan","year":"2022","unstructured":"Fan R et al (2022) Importance of Bmal1 in Alzheimer\u2019s disease and associated aging-related diseases: mechanisms and interventions. Aging cell 21(10):e13704","journal-title":"Aging cell"},{"key":"4685_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-10-1","volume":"10","author":"H Song","year":"2015","unstructured":"Song H et al (2015) A\u03b2-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer\u2019s disease. Mol Neurodegener 10:1\u201315","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4685_CR87","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41598-022-05862-z","volume":"12","author":"CA McKee","year":"2022","unstructured":"McKee CA et al (2022) Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden. Sci Rep 12(1):1796","journal-title":"Sci Rep"},{"issue":"4","key":"4685_CR88","doi-asserted-by":"publisher","first-page":"18515","DOI":"10.4238\/2015.December.23.39","volume":"14","author":"Q Chen","year":"2015","unstructured":"Chen Q et al (2015) Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population. Genet Mol Res 14(4):18515\u201318522. https:\/\/doi.org\/10.4238\/2015.December.23.39","journal-title":"Genet Mol Res"},{"issue":"21","key":"4685_CR89","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.3390\/ijms21217862","volume":"21","author":"ID Yoo","year":"2020","unstructured":"Yoo ID et al (2020) Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer\u2019s disease. Int J Mol Sci 21(21):7862. https:\/\/doi.org\/10.3390\/ijms21217862","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4685_CR90","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/glia.23754","volume":"68","author":"AA Ali","year":"2020","unstructured":"Ali AA et al (2020) Bmal1-deficiency affects glial synaptic coverage of the hippocampal mossy fiber synapse and the actin cytoskeleton in astrocytes. Glia 68(5):947\u2013962","journal-title":"Glia"},{"issue":"1","key":"4685_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.09.015","volume":"25","author":"BV Lananna","year":"2018","unstructured":"Lananna BV et al (2018) Cell-autonomous regulation of astrocyte activation by the circadian clock protein BMAL1. Cell Rep 25(1):1-9. e5","journal-title":"Cell Rep"},{"issue":"2","key":"4685_CR92","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M et al (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28(2):203\u2013209","journal-title":"Ann Gastroenterol"},{"issue":"11","key":"4685_CR93","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","volume":"10","author":"SM Collins","year":"2012","unstructured":"Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10(11):735\u2013742. https:\/\/doi.org\/10.1038\/nrmicro2876","journal-title":"Nat Rev Microbiol"},{"key":"4685_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:49. https:\/\/doi.org\/10.3389\/fnins.2018.00049","journal-title":"Front Neurosci"},{"issue":"1","key":"4685_CR95","doi-asserted-by":"publisher","first-page":"1957407","DOI":"10.1080\/19490976.2021.1957407","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer\u2019s disease and their potential links in the pathogenesis. Gut Microbes 13(1):1957407. https:\/\/doi.org\/10.1080\/19490976.2021.1957407","journal-title":"Gut Microbes"},{"issue":"12","key":"4685_CR96","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1016\/j.apsb.2023.08.009","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023) Targeting the blood\u2013brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays. Acta Pharmaceutica Sinica B 13(12):4667\u20134687. https:\/\/doi.org\/10.1016\/j.apsb.2023.08.009","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"3","key":"4685_CR97","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cmet.2020.02.008","volume":"31","author":"EM Teichman","year":"2020","unstructured":"Teichman EM et al (2020) When rhythms meet the blues: circadian interactions with the microbiota-gut-brain axis. Cell Metab 31(3):448\u2013471","journal-title":"Cell Metab"},{"issue":"7","key":"4685_CR98","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/07420528.2020.1778717","volume":"37","author":"H Mortas","year":"2020","unstructured":"Mortas H, Bilici S, Karakan T (2020) The circadian disruption of night work alters gut microbiota consistent with elevated risk for future metabolic and gastrointestinal pathology. Chronobiol Int 37(7):1067\u20131081. https:\/\/doi.org\/10.1080\/07420528.2020.1778717","journal-title":"Chronobiol Int"},{"key":"4685_CR99","doi-asserted-by":"publisher","first-page":"35405","DOI":"10.1038\/srep35405","volume":"6","author":"VA Poroyko","year":"2016","unstructured":"Poroyko VA et al (2016) Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep 6:35405. https:\/\/doi.org\/10.1038\/srep35405","journal-title":"Sci Rep"},{"issue":"4","key":"4685_CR100","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/19490976.2019.1701352","volume":"11","author":"J Triplett","year":"2020","unstructured":"Triplett J et al (2020) Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats. Gut Microbes 11(4):706\u2013720. https:\/\/doi.org\/10.1080\/19490976.2019.1701352","journal-title":"Gut Microbes"},{"issue":"3","key":"4685_CR101","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cell.2014.09.048","volume":"159","author":"CA Thaiss","year":"2014","unstructured":"Thaiss CA et al (2014) Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell 159(3):514\u2013529. https:\/\/doi.org\/10.1016\/j.cell.2014.09.048","journal-title":"Cell"},{"issue":"2","key":"4685_CR102","doi-asserted-by":"publisher","first-page":"e0229001","DOI":"10.1371\/journal.pone.0229001","volume":"15","author":"SJ Bowers","year":"2020","unstructured":"Bowers SJ et al (2020) Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome. PLoS One 15(2):e0229001. https:\/\/doi.org\/10.1371\/journal.pone.0229001","journal-title":"PLoS One"},{"issue":"1","key":"4685_CR103","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12866-019-1535-2","volume":"19","author":"KM Klimina","year":"2019","unstructured":"Klimina KM et al (2019) The effects of desynchronosis on the gut microbiota composition and physiological parameters of rats. BMC Microbiol 19(1):160. https:\/\/doi.org\/10.1186\/s12866-019-1535-2","journal-title":"BMC Microbiol"},{"issue":"11","key":"4685_CR104","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1007\/s10620-019-05675-7","volume":"64","author":"J Amara","year":"2019","unstructured":"Amara J et al (2019) Circadian rhythm disruption aggravates DSS-induced colitis in mice with fecal calprotectin as a marker of colitis severity. Dig Dis Sci 64(11):3122\u20133133. https:\/\/doi.org\/10.1007\/s10620-019-05675-7","journal-title":"Dig Dis Sci"},{"issue":"11","key":"4685_CR105","doi-asserted-by":"publisher","first-page":"zsx141","DOI":"10.1093\/sleep\/zsx141","volume":"40","author":"A Pocivavsek","year":"2017","unstructured":"Pocivavsek A et al (2017) Acute kynurenine challenge disrupts sleep-wake architecture and impairs contextual memory in adult rats. Sleep 40(11):zsx141. https:\/\/doi.org\/10.1093\/sleep\/zsx141","journal-title":"Sleep"},{"key":"4685_CR106","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60\u201368. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.019","journal-title":"Neurobiol Aging"},{"key":"4685_CR107","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: A Randomized, Double-Blind and Controlled Trial. Front Aging Neurosci 8:256. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","journal-title":"Front Aging Neurosci"},{"key":"4685_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.phrs.2018.07.007","volume":"136","author":"VJR de De-Paula","year":"2018","unstructured":"de De-Paula VJR, Forlenza AS, Forlenza OV (2018) Relevance of gutmicrobiota in cognition, behaviour and Alzheimer\u2019s disease. Pharmacol Res 136:29\u201334. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.007","journal-title":"Pharmacol Res"},{"issue":"5","key":"4685_CR109","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/jnc.15701","volume":"163","author":"D Meng","year":"2022","unstructured":"Meng D et al (2022) Rifaximin protects against circadian rhythm disruption-induced cognitive impairment through preventing gut barrier damage and neuroinflammation. J Neurochem 163(5):406\u2013418. https:\/\/doi.org\/10.1111\/jnc.15701","journal-title":"J Neurochem"},{"key":"4685_CR110","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ijbiomac.2022.07.090","volume":"217","author":"Y Sun","year":"2022","unstructured":"Sun Y et al (2022) Dendrobium officinale polysaccharide attenuates cognitive impairment in circadian rhythm disruption mice model by modulating gut microbiota. Int J Biol Macromol 217:677\u2013688. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.090","journal-title":"Int J Biol Macromol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04685-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:08:40Z","timestamp":1743379720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04685-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4685"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04685-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}